5,054
Views
62
CrossRef citations to date
0
Altmetric
Original Articles

Health Effects of Probiotics on the Skin

, , &

REFERENCES

  • Abrahamsson, T., Jakobsson, T., Bottcher, M., Fredrikson, M., Jenmalm, M. and Oldaeus, N.B. G. (2007). Probiotics in prevention of IgE-associated eczema: A double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119:1174–1180.
  • Adebamowo, C.A., Spiegelman, D., Berkey, C.S., Danby, F.W., Rockett, H.H., Colditz, G.A., Willett, W.C. and Holmes, M.D. (2006). Milk consumption and acne in adolescent girls. Dermatol. Online J. 12:1.
  • Adebamowo, C.A., Spiegelman, D., Berkey, C.S., Danby, F.W., Rockett, H.H., Colditz, G.A.C. Willett, W.C. and Holmes, M.D. (2008). Milk consumption and acne in teenaged boys. J. Am. Acad. Dermatol. 58:787–793.
  • Adebamowo, C.A., Spiegelman, D., Danby, F.W., Frazier, A.L., Willett, W.C. and Holmes, M.D. (2005). High school dietary dairy intake and teenage acne. J. Am. Acad. Dermatol. 52:207–214.
  • Adkinson, N.F. J., Busse, W.W., Bochner, B.S., Holgate, S.T., Simons, F.E. R. and Lemanske, R.F. (2009). Middleton's Allergy: Principles and Practice, 7th ed., Mosby, Philadelphia.
  • Al-Ghazzewi, F.H. and Tester, R.F. (2009). Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Int. J. Cosmet. Sci. 32:139–142.
  • Al-Ghazzewi, F.H. and Tester, R.F. (2010). Effect of konjac glucomannan hydrolysates and probiotics on the growth of the skin bacterium Propionibacterium acnes in vitro. Int. J. Cosmet. Sci. 32:139–142.
  • Alm, J.S. (2002). An anthroposophic lifestyle and intestinal microflora in infancy. Pediatr. Allergy Immunol. 3:402–411.
  • Anon. (1993). Severity scoring of atopic dermatitis: The SCORAD index: Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 186:23–31.
  • Anon. (2006). FAO/WHO. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food.
  • Arck, P., Handjiski, B., Hagen, E., Pincus, M., Bruenahl, C., Bienenstock, J. and Paus, R. (2010). Is there a ‘gut-brain-skin axis’? Exp. Dermatol. 19:401–405.
  • Arikawa, J., Ishibashi, M., Kawashima, M., Takagi, Y., Ichikawa, Y. and Imokawa, G. (2002). Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J. Invest. Dermatol. 119:433–439.
  • Arslanoglu, S., Moro, G.E., Schmitt, J., Tandoi, L., Rizzardi, S. and Boehm, G. (2008). Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. J. Nutr. 138:1091–1095.
  • Baba, H., Masuyama, A. and Takano, T. (2006). Effects of Lactobacillus helveticus-fermented milk on the differentiation of cultured normal human epidermal keratinocytes. J. Dairy Sci. 89:2072–2075.
  • Bard, S., Kroshinsky, D., Solomon, H. and Glick, S. (2008). A prospective randomized, double-blinded, placebo-controlled pilot study of lactobacillus GG in the treatment of atopic dermatitis. J. Am. Acad. Dermatol. 53:S620.
  • Baur, M., Breton, L., Couzy, F. and Gueniche, A. (2003). Use of Probiotic Lactic Acid Bacteria for Balancing the Skin's Immune System. 20040013706.
  • Bernet-Camard, M.F., Lievin, V., Brassart, D., Neeser, J.R., Servin, A.L. and Hudault, H. (1997). The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63:2747–2753.
  • Bernstein, E.F., Brown, D.B., Schwarz, M.D., Kaidbey, K. and Ksenzenko, S.M. (2004). The polyhydroxy acid gluconolactone protects against ultraviolet radiation in an in vitro model of cutaneous photoaging. Dermatol. Surg. 30:189–196.
  • Bockmühl, D., Jasoy, C., Nieveler, S., Scholtyssek, R., Wadle, A. and Waldmann-Laue, M. (2006). Prebiotic cosmetics: An alternative to antibacterial products. IFSSC Mag. 9:1–5.
  • Bouilly-Gauthier, D., Jeannes, C., Maubert, Y., Duteil, L., Queille-Roussel, C., Piccardi, N., Montastier, C., Manissier, P., Pierard, G. and Ortonne, J.P. (2010). Clinical evidence of benefits of a dietary supplement containing probiotic and carotenoids on ultraviolet-induced skin damage. Br. J. Dermatol. 163:534–543.
  • Bowe, W.P., Filip, J.C., Dirienzo, J.M., Volgina, A. and Margolis, D.J. (2006). Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius. J. Drugs Dermatol. 5:868–870.
  • Bowe, W.P. and Logan, A.C. (2010). Clinical implications of lipid peroxidation in acne: Old wine in new bottles. Lipids Health Dis. 9:141–151.
  • Bowe, W.P. and Logan, A.C. (2011). Acne vulgaris, probiotics and the gut-brain-skin axis—back to the future? Gut Pathogens 3:1–11.
  • Boyle, R.J., Bath-Hextall, F.J., Leonardi-Bee, J. and Al., E. (2009). Probiotics for the treatment of eczema: A systematic review. Clin. Exp. Allergy 39:1117–27.
  • Boyle, R.J. and Tang, M.L. K. (2006). The role of probiotics in the management of allergic disease. Clin. Exp. Allergy 36:568–576.
  • Brouwer, M.L., Wolt-Plompen, S.A. and Dubois, A.E. (2006). No effects of probiotics on atopic dermatitis in infancy: A randomized placebo-controlled trial. Clin. Exp. Allergy 36:899–906.
  • Bunselmeyer, B. and Buddendick, K. (2010). Probiotics and prebiotics-prevention and therapy in atopic eczema. In: Bioactive Foods in Promoting Health: Probiotics and Prebiotics. Watson, R.R. and Preedy, V.R., Eds., Elsevier, USA.
  • Caffarelli, C., Cavagni, G., Menzies, I.S., Bertolini, P. and Atherton, D.J. (1993). Elimination diet and intestinal permeability in atopic eczema: A preliminary study. Clin. Exp. Allergy 23:28–31.
  • Caramia, G., Atzei, A. and Fanos, V. (2008). Probiotics and the skin. Clin. Dermatol. 26:4–11.
  • Carroll, C.L., Balkrishnan, R., Feldman, S.R., Fleischer, A.B. J. and Manuel, J.C. (2005). The burden of atopic dermatitis: Impact on the patient, family, and society. Pediatr. Dermatol. 22:192–199.
  • Cazzola, M., Tompkins, T.A. and Matera, M.G. (2010). Immunomodulatory impact of a synbiotic in T(h)1 and T(h)2 models of infection. Ther. Adv. Respir. Dis. 4:259–270.
  • Chapat, L., Chemin, K., Dubois, B., Bourdet-Sicard, R. and Kaiserlian, D. (2004). Lactobacillus casei reduces CD8+ T cell-mediated skin inflammation. Eur. J. Immunol. 34:2520–2528.
  • Charman, C. and Williams, H. (2000). Outcome measures of disease severity in atopic eczema. Arch. Dermatol. 136:763–769.
  • Chiba, K. (2007). Development of functional cosmetic ingredients using lactic acid bacteria in Japan. Jpn. J. Lactic Acid Bact. 18:105–112.
  • Cinque, B., Palumbo, P., La Torre, C., Melchiorre, E., Corridoni, D., Miconi, G., Di Marzio, L., Cifone, M.G. and Giuliani, M. (2010). Probiotics in aging skin. In: Textbook of Aging Skin, Farage, M. A., Miller, K. W., and Maibach, H. I., eds. Springer, Berlin.
  • Cinque, B., Torre, C., Melchiorre, E., Marchesani, G., Zoccali, G., Palumbo, P., Marzio, L.D., Masci, A., Mosca, L., Mastromarino, P., Giuliani, M. and Cifone, M.G. (2011). Use of probiotics for dermal applications. In: Probiotics, Microbiology Monographs. Liong, M.-T., Ed., Springer Verlag, Berlin, Heidelberg.
  • Coconnier, M.H., Lievin, V., Hemery, E. and Servin, A.L. (1998). Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol. 64:4573–4580.
  • Cogen, A.L., Nizet, V. and Gallo, R.L. (2008). Skin microbiota: A source of disease or defense? Br. J. Dermatol. 158:442–455.
  • Cosseau, C., Devine, D.A., Dullaghan, E., Gardy, J.L., Chikatamarla, A., Gellatly, S., Yu, L.L., Pistolic, J., Falsafi, R., Tagg, J. and Hancock, R.E. W. (2008). The commensal Streptococcus salivarius K12 downregulates the innate immune responses of human epithelial cells and promotes hostmicrobe homeostasis. Infect. Immunol. 76:4163–4175.
  • Cross, M.L. (2002). Immunoregulation by probiotic lactobacilli: Pro-Th1 signals and their relevance to human health. Clin. Appl. Immunol. Rev. 3:115–125.
  • De Simone, C. (2003). Use of Bacteria Endowed with Arginine Deiminase to Induce Apoptosis and/or Reduce an Inflammatory Reaction and Pharmaceutical or Dietetic Compositions Containing Such Bacteria.
  • del Giudice Jr, M.M., De Luca, M.G. and Capristo, C. (2002). Probiotics and atopic dermatitis. A new strategy in atopic dermatitis. Digest. Liver Dis. 34:S68–S71.
  • Della Riccia, D.N., Bizzini, F., Perilli, M.G., Polimeni, A., Trinchieri, V., Amicosante, G. and Cifone, M.G. (2007). Anti-inflammatory effects of Lactobacillus brevis (CD2) on periodontal disease. Oral Dis. 13:376–385.
  • Di Marzio, L., Centi, C., Cinque, B., Masci, S., Giuliani, M. and Arcieri, A. (2003). Effect of the lactic acid bacterium streptococcus thermophilus on stratum corneum ceramide levels and signs and symptoms of atopic dermatitis patients. Exp. Dermatol. 12:615–620.
  • Di Marzio, L., Cinque, B., Cupelli, F., De Simone, C., Cifone, M.G. and Giuliani, M. (2008). Increase of skin-ceramide levels in aged subjects following a short-term topical application of bacterial sphingomyelinase from Streptococcus thermophilus. Int. J. Immunopathol. Pharmacol. 21:137–143.
  • Di Marzio, L., Cinque, B., De Simone, C. and Cifone, M.G. (1999). Effect of the lactic acid bacterium Streptococcus thermophilus on ceramide levels in human keratinocytes in vitro and stratum corneum in vivo. J. Invest Dermatol. 113:98–106.
  • Di Marzio, L., Russo, F.P., D’ALò, S., Biordi, L., Ulisse, S., Amicosante, G., De Simone, C. and Cifone, M.G. (2001). Apoptotic effects of selected strains of lactic acid bacteria on a human T leukemia cell line are associated with bacterial arginine deiminase and/or sphingomyelinase activities. Nutr. Cancer 40:185–196.
  • Duramad, P., Harley, K. and Lipsett, M. (2006). Early environmental exposures and intracellular Th1/Th2 cytokine profiles in 24-month-old children living in an agricultural area. Environ. Health Perspect. 114:1916–1922.
  • Eady, E.A. and Ingham, E. (1994). Propionibacterium acnes-friend or foe? Rev. Med. Microbiol. 5:163–173.
  • Elias, P.M. and Choi, E.H. (2005). Interactions among stratum cormeum defensive functions. Exp. Dermatol. 14:719–726.
  • Euvrard, S., Kanitakis, J. and Claudy, A. (2003). Skin cancers after organ transplantation. N. Engl. J. Med. 348:1681–1691.
  • Farid, R., Ahanchian, H., Jabbari, F. and Moghiman, T. (2011). Effect of a new synbiotic mixture on atopic dermatitis in children: A randomized-controlled trial. Iran. J. Pediatr. 21:225–230.
  • Farmer, S. (2005). Topical Compositions Containing Probiotic Bacillus Bacteria, Spores, and Extracellular Products and Uses Thereof. 14 June 2005 patent application.
  • Feingold, K.R. (2007). Thematic review series: Skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis. J. Lipid Res. 48:2531–2546.
  • Feleszko, W., Jaworska, J., Rha, R.D., Steinhausen, S., Avagyan, A., Jaudszus, A., Ahrens, B., Groneberg, D.A., Wahn, U. and Hamelmann, E. (2007). Probioticinduced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mecha-nisms in a murine model of asthma. Clin. Exp. Allergy 37:498–505.
  • Fink, L.N. (2010). Induction of regulatory T cells by probiotics: Potential for treatment of allergy? Clinl. Exper. Allergy 40:5–8.
  • Flinterman, A.E., Knol, E.F., van Ieperen-van Dijk, A.G., Timmerman, H.M., Knulst, A.C., Bruijnzeel-Koomen, C.A., Pasmans, S.G. and van Hoffen, E. (2007). Probiotics have a different immunomodulatory potential in vitro versus ex vivo upon oral administration in children with food allergy. Int. Arch. Allergy Immunol. 143:237–244.
  • Flohr, C., Pascoe, D. and Williams, H.C. (2005). Atopic dermatitis and the ehygiene hypothesisf: Too clean to be true? Br. J. Dermatol. 152:202–216.
  • Folster-Holst, R., Müller, F., Schnopp, N., Abeck, D., Kreiselmaier, I., Lenz, T., von Rüden, U., Schrezenmeir, J., Christophers, E. and Weichenthal, M. (2006). Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br. J. Dermatol. 155:1256–1261.
  • Fu, Y.R., Yi, Z.J., Pei, J.L. and Guan, S. (2010). Effects of Bifidobacterium bifidum on adaptive immune senescence in aging mice. Microbiol. Immunol. 54:578–583.
  • Fukushima, Y., Kawata, Y., Mizumachi, K., Kurisaki, J. and Mitsuoka, T. (1999). Effect of bifidobacteria feeding on fecal flora and production of immunoglobulins in lactating mouse. Int. J. Food Microbiol. 46: 193–197.
  • Ghadimi, D., Fölster-Holst, R., de Vrese, M., Winkler, P., Heller, K.J. and Schrezenmeir, J. (2008). Effects of probiotic bacteria and their genomic DNA on TH1/TH2-cytokine production by peripheral blood mononuclear cells (PBMCs) of healthy and allergic subjects. Immunobiology 213:677–692.
  • Gill, H. and Prasad, J. (2008). Probiotics, immunomodulation, and health benefits. Adv. Exp. Med. Biol. 606:423–454.
  • Gillor, O., Etzion, A. and Riley, M.A. (2008). The dual role of bacteriocins as anti- and probiotics. Appl. Microbiol. Biotechnol. 81:591–606.
  • Grice, E.A., Kong, H.H., Renaud, G., Young, A.C., Bouffard, G.G. and Blakesley, R.W. (2008). A diversity profile of the human skin microbiota. Genome Res. 18:1043–1050.
  • Gromert, N. and Axelsson, I. (2009). Dietary supplementation with Lactobacillus reuteri ATCC 55730 and its effect on atopic eczema in childhood. In: Proceedings for the 42nd European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN).
  • Grüber, C., Wendt, M., Sulser, C., Lau, S., Kulig, M., Wahn, U., Werfel, T. and Niggemann, B. (2007). Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 62:1270–1276.
  • Guenche, A., Benyacoub, J., Buetler, T.M., Smola, H. and Blum, S. (2006). Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur. J. Dermatol. 16:511–517.
  • Gueniche, A. (2010a). Use of Probiotic Microorganisms to Limit Skin Irritation. US Patent, US20100226892.
  • Gueniche, A., Bastien, P., Ovigne, J.M., Kermici, M., Courchay, G. and Chevalier, V. (2010b). Bifidobacterium longum lysate, a new ingredient for reactive skin. Exp. Dermatol. 19:1–8.
  • Gueniche, A., Benyacoub, J., Blum, S., Breton, L. and Castiel, I. (2009). Probiotics for skin benefits. In: Nutritional Cosmetics: Beauty from Within. Tabor, A. and Blair, R.M., Eds., William Andrew Applied Science Publishers/Elsevier.
  • Gueniche, A., Benyacoub, J., Breton, L., Bastien, P., Bureau-Fanz, I., Blum, S. and Leclaire, J. (2007). A combination of Lactobacillus paracasei CNCM I-2116 and Bifidobacterium lactis CNCM I-3446 probiotic strains decreases skin reactivity. J. Invest. Dermatol. 102:S17.
  • Gueniche, A., Benyacoub, J., Buetler, T.M., Smola, H. and Blum, S. (2006). Supplementation with oral probiotic bacteria maintains cutaneous immune homeostasis after UV exposure. Eur. J. Dermatol. 16:511–517.
  • Gueniche, A., Benyacoub, J., Philippe, D., Bastien, P., Kusy, N. and Breton, L. (2010a). Lactobacillus paracasei CNCM I-2116 (ST11) inhibits substance P-induced skin inflammation and accelerates skin barrier function recovery in vitro. Eur. J. Dermatol. 20:731–737.
  • Hacini-Rachinel, F., Gheit, H., Le Luduec, J.B., Dif, F., Nancey, S. and Kaiserlian, D. (2009). Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. PLoS One 4:4903–4911.
  • Halken, S. (2004). Prevention of allergic disease in childhood: Clinical and epidemiological aspects of primary and secondary allergy prevention. Pediatr. Allergy Immunol. 4–5:9–32.
  • Halper, J., Leshin, L.S., Lewis, S.J. and Li, W.I. (2003). Wound healing and angiogenic properties of supernatants from Lactobacillus cultures. Exp. Biol. Med. 228:1329–1337.
  • Halvarsson, K. and Lodén, M. (2007). Increasing quality of life by improving the quality of skin in patients with atopic dermatitis. Int. J. Cosmet. Sci. 29:69–83.
  • Hancox, J.G., Sheridan, S.C., Feldman, S.R. and Fleischer, A.B. (2004). Seasonal variation of dermatologic disease in the USA: A study of office visits from 1990 to 1998. Int. J. Dermatol. 43:6–11.
  • Hansen, J.E. and Jespersen, L.K. (2010). Wound or Tissue Dressing Comprising Lactic Acid Bacteria. 10 June 2010 patent application.
  • Harmesen, H.J., Gibson, G.R., Elfferich, P., Raanags, G.C., Wildeboer-Veloo, A.C. and Argaiz, A. (2000). Comparison of viable ell counts and fluorescence in situ hybridization using specific rRNA-based probes for the quantification of human feel bacteria. FEMS Microbiol. Lett. 183:125–129.
  • Hattori, K., Yamamoto, A. and Sasai, M. (2003). Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. 52, 20–30.
  • Hessle, C., Hanson, L.A. and Wold, A.E. (1999). Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol. 116:276–282.
  • Heydari, S., Mortazavian, A.M., Ehsani, M.R., Mohammadifar, M.A., Ezzatpanah, H. and Sohrabvandi, S. (2011). Biochemical, microbiological and sensory characteristics of probiotic yougurt containing various prebiotic or fiber compounds. Ital. J. Food Sci. 23:153–163.
  • Holland, K.T. and Bojar, R.A. (2002). Cosmetics. What is their influence on the skin microflora? Am. J. Clin. Dermatol. 3:445–449.
  • Holma, R., Kekkonen, R.A., Hatakka, K.H., Poussa, T., Vaarala, O., Adlercreutz, H. and Korpela, R. (2011). Consumption of Galactooligosaccharides Together with Probiotics Stimulates the in vitro Peripheral Blood Mononuclear Cell Proliferation and IFNγ Production in Healthy Men. ISRN Immunology, 2011: 1–6.
  • Hou, J.W., Yu, R.C. and Chou, C.C. (2000). Changes in some components of soymilk during fermentation with bifidobacteria. Food Res. Int. 33:393–397.
  • Isolauri, E., Arvola, T. and Sutäs, Y. (2000). Probiotics in the management of atopic eczema. Clin. Exp. Allergy 30:1604–1610.
  • Isolauri, E., Pelto, L., Nuutila, J., Majamaa, H., Lilius, E.-M. and Salminen, S. (1997). Altered expression of IgG and complement receptors indicates a significant role of phagocytes in atopic dermatitis. J. Allergy Clin. Immunol. 99: 707–713.
  • Isolauri, E., Sutas, Y., Kankaanpaa, P., Arvilommi, H. and Salminen, S. (2001). Probiotics: Effects on immunity. Am. J. Clin. Nutr. 73:444S–450S.
  • Ji, G.E. (2009). Probiotics in primary prevention of atopic dermatitis. Forum. Nutr. 61:117–128.
  • Johnson, C.C., Ownby, D.R. and Alford, S.H. (2005). Antibiotic exposure in early infancy and risk for childhood atopy. J. Allergy Clin. Immunol. 115:1218–1224.
  • Jones, M.L., Ganopolsky, J.G., Labbe, A. and Prakash, S. (2010). A novel nitric oxide producing probiotic patch and its antimicrobial efficacy: Preparation and in vitro analysis. Appl. Microbiol. Biotechnol. 87:509–516.
  • Kalliomäki, M., Salminen, S. and Arvilommi, H. (2001). Probiotics in primary prevention of atopic disease: A randomised placebo-controlled trial. Lancet 357:1076–1079.
  • Kalliomäki, M., Salminen, S. and Poussa, T. (2003). Probiotics and prevention of atopic disease: R-year follow-up of a randomised placebo-controlled trial. Lancet 361:1869–1871.
  • Kalliomäki, M., Salminen, S., Poussa, T. and Isolauri, E. (2007). Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 119:1019–1021.
  • Kang, S.H., Kim, J.U., Imm, J.Y., Oh, S. and Kim, S.H. (2006). The effects of dairy processes and storage on insulin-like growth factor-I (IGF-I) content in milk and in model IGF-I-fortified dairy products. J. Dairy Sci. 89:402–409.
  • Kang, B.S., Seo, J.G., Lee, G.S., Kim, J.H., Kim, S.Y., Han, Y.W. and Al., E. (2009). Antimicrobial activity of enterocins from Enterococcus faecalis SL-5 against Propionibacterium acnes, the causative agent in acne vulgaris, and its therapeutic effect. J. Microbiol. 47:101–109.
  • Kankaanpaa, P., Sutas, Y., Arvilommi, H., Salminen, S. and Isolauri, E. (1998). Comparison of antiproliferative effects of probiotic cell extracts and glucocorticoids. Gastroenterol. Int. 11:S139–S146.
  • Kankaanpaa, P.E., Yang, B., Kallio, H.P., Isolauri, E. and Salminen, S.J. (2002). Influence of probioticsupplementedinfant formulaon composition of plasma lipidsin atopicinfants. J. Nutr. Biochem. 13:364–369.
  • Karimi, R., Mortazavian, A.M. and Amiri-Rigi, A. (2012). Selective enumeration of probiotic microorganisms in cheese. Food Microbiol. 29:1–9.
  • Karimi, R., Mortazavian, A.M. and Cruz, A.G. (2011). Viability of probiotic microorganisms in cheese during production and storage: A review. Dairy Sci. Technol. 91:283–308.
  • Kidd, P. (2003). Th1/Th2 balance: The hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223–246.
  • Kim, J., Ko, Y., Park, Y.K., Kim, N.I., Ha, W.K. and Cho, Y. (2010). Dietary effect of lactoferrinenriched fermented milk on skin surface lipid and clinical improvement of acne vulgaris. Nutr. Cancer 26:902–909.
  • Kim, J.Y., Kwon, J.H., Ahn, S.H., Lee, S.I., Han, Y.S., Choi, Y.O., Lee, S.Y., Ahn, K.M. and Ji, G.E. (2009). Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Pediatr. Allergy Immunol. 21:e386–e393.
  • Kirjavainen, P.V., Arvola, T., Salminen, S.J. and Isolauri, E. (2002). Aberrant composition of gut microbiota of allergic infants. a target of bifidobacterial therapy at weaning? Gut 51, 51–55.
  • Kirjavainen, P.V., Apostolou, E., Salminen, S.J. and Isolauri, E. (1999). New aspects of probiotics - a novel approach in the management of food allergy. Allergy 54:909–915.
  • Kirjavainen, P.V., Salminen, S.J. and Isolauri, E. (2003). Probiotic bacteria in the management of atopic disease: Underscoring the importance of viability. J. Pediatr. Gastroenterol. Nutr. 36:223–227.
  • Kliegman, R.M., Behrman, R.E., Jenson, H.B. and Stanton, B.F. (2007). Nelson Textbook of Pediatrics. Saunders, Philadelphia.
  • Kodali, V.P. and Sen, R. (2008). Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol. J. 3:245–251.
  • Kopp, M., Hennemuth, I., Heinzmann, A. and Urrbanek, R. (2008). Randomized, double-blind, placebo-controlled trial for primary prevention: No clinical effects of Lactobacillus GG supplementation. Pediatrics 121:1–7.
  • Kopp, M.V. and Salfeld, P. (2009). Probiotics and prevention of allergic disease. Curr. Opin. Clin. Nutr. Metab. Care. 12:298–303.
  • Korbekandi, H., Mortazavian, A.M. and Iravani, S. (2011). Technology and stability of probiotic in fermented milks. In: Probiotic and Prebiotic Foods: Technology, Stability and Benefits to the Human Health. Shah, N.P., Ed., Nova Science Publishers, New York.
  • Kruisselbrink, A., Bak-Glashouwer, M.J. H. D., Havenith, C.E., Thole, J.E. and Janssen, R. (2001). Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses. Clin. Exp. Immunol. 126:2–8.
  • Krutmann, J. (2009). Pre- and probiotics for human skin. J. Dermatol. Sci. 54:1–5.
  • Kuitunen, M., Kukkonen, K., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T., Haahtela, T. and Savilahti, E. (2009). Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort. J. Allergy Clin. Immunol. 123:335–341.
  • Kukkonen, K., Savilahti, E. and Haahtela, T. (2008). Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: Randomized, double-blind, placebo-controlled trial. Pediatrics 122:8–12.
  • Kukkonen, K., Savilahti, E., Haahtela, T., Juntunen-Backman, K., Korpela, R., Poussa, T., Tuure, T. and Kuitunen, M. (2007). Probiotics and prebiotics galacto-oligosaccharides in the prevention of allergic disease: A randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 119:192–198.
  • Kummeling, I., Stelma, F.F. and Dagnelie, P.C. (2007). Early life exposure to antibiotics and the subsequent development of eczema, wheeze, and allergic sensitization in the first 2 years of life: The KOALA Birth Cohort Study. Pediatrics 119:225–231.
  • Kunz, B., Oranje, A.P. and Labreze, L. (1997). Clinical validation and guidelines for the SCORAD index: Consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195:9–10.
  • Lakshini, A.V. (1998). Riboflavin metabolism-relevance to human nutrition. Ind. J. Med. Res. 108:182–190.
  • Lammers, K.M., Brigidi, P. and Vitali, B. (2003). Immunomodulatory effects of probiotic bacteria DNA: Il-1 and IL-10 response in human peripheral blood mononucelar cells. FEMS Immunol. Med. Microbiol. 38:165–172.
  • Lambers, H., Piessens, S., Bloem, A., Pronk, H. and Finkel, P. (2006). Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int. J. Cosmet. Sci. 28:359–370.
  • Laughter, D., Istvan, J.A., Tofte, S.J. and Hanifin, J.M.. (2000). The prevalence of atopic dermatitis in Oregon schoolchildren. J. Am. Acad. Dermatol. 43:649–655.
  • Lee, W.J., Jung, H.D., Lee, H.J., Kim, B.S., Lee, S.J. and Kim Do, W. (2008b). Influence of substance-P on cultured sebocytes. Arch. Dermatol. Res. 300:311–316.
  • Lee, T.T., Morisset, M., Astier, C., Moneret-Vautrin, D.A., Cordebar, V., Beaudouin, E., Codreanu, F., Bihain, B.E. and Kanny, G. (2007). Contamination of probiotic preparations with milk allergens can cause anaphylaxis in children with cow's milk allergy. J. Allergy Clin. Immunol. 119:746–747.
  • Lee, J., Seto, D. and Bielory, L. (2008a). Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J. Allergy Clin. Immunol. 121:116–121.
  • Leyden, J.J., Mcginley, K.J. and Bowels, B. (1998). Propionibacterium acnes colonization in acne and nonacne. Dermatology 196:55–58.
  • Leyden, J.J., Mcginley, K.J., Nordstrom, K.M. and Webster, G.F. (1987). Skin microflora. J. Invest. Dermatol. 88:65s–72s.
  • Lin, M.Y. and Chang, F.J. (2000). Antioxidative effect of intestinal bacteria Bifidobacterium longum ATCC 15708 and Lactobacillus acidophilus ATCC 4356. Dig. Dis. Sci. 45:1617–1622.
  • Ling, E.M., Smith, T., Nguyen, X.D., Pridgeon, C., Dallman, M. and Arbery, J. (2004). Relation of CD41CD251 regulatory T-cell suppression of allergendriven T-cell activation to atopic status and expression of allergic disease. Lancet 363:608–615.
  • Ly, N.P., Litonjua, A., Gold, D.R. and Celedón, J.C. (2011). Gut microbiota, probiotics, and vitamin D: Interrelated exposures influencing allergy, asthma, and obesity? J. Allergy Clin. Immunol. 127:1087–1094.
  • Ma, D., Forsythe, P. and Bienenstock, J. (2004). Live Lactobacillus reuteri is essential for the inhibitory effect on tumour necrosis factor alpha-induced Interleukin-8 expression. Infect. Immunol. 72:5308–5314.
  • Macpherson, A.J. and Harris, N.L. (2004). Opinion: Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 4:478–485.
  • Majamaa, H. and Isolauri, E. (1997). Probiotics: A novel approach in the management of food allergy. J. Allergy Clin. Immunol. 99:179–185.
  • Marchetti, F., Capizzi, R. and Tulli, A. (1987). Efficacy of regulators of the intestinal bacterial flora in the therapy of acne vulgaris. Clin. Ter. 122:339–343.
  • Mauro, T. (2006). SC pH: Measurement, origins, and functions. In: Skin Barrier. Elias, P. and Feingold, K., Eds., Taylor & Francis, New York.
  • Melnik, B.C. and Schmitz, G. (2009). Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris. Exp. Dermatol. 18:833–841.
  • Metze, D., Kerssten, A., Jurecka, W. and Gebhart, W. (1991). Immunoglobulins coat microorganisms of skin surface: A comparative immunohistochemical and ultrastructural study of cutaneous and oral microbial symbionts. J. Invest. Dermatol. 96:439–445.
  • Michail, S. (2009). The role of Probiotics in allergic diseases. Allergy Asthma Clin. Immunol. 5:1–7.
  • Michail, S., Onady, G., Stolfi, A. and Johnson, T. (2008). Efficacy of probiotics in treatment of pediatric atopic dermatitis a meta-analysis of randomized, controlled trials. Ann. Allergy Asthma Immunol. 101:508–516.
  • Miettinen, M., Matikainen, S., Vuopio-Varkila, J., Pirhonen, J., Varkila, K., Kurimoto, M. and Julkunen, I. (1998). Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immunol. 66:6058–6062.
  • Mikelsaar, M. and Zilmer, M. (2009). Lactobacillus fermentum ME-3 - an antimicrobial and antioxidative probiotic. Microb. Ecol. Health Dis. 21:1–27.
  • Miraglia, D.G. M. and De Luca, M.G. (2004). The role of probiotics in the clinical management of food allergy and atopic dermatitis. J. Clin. Gastroenterol. 38:S84–S85.
  • Miyazaki, K. (2003). Bifidobacterium-fermented soy milk extract stimulates hylauronic acid production in human skin cells and hairless mouse skin. Skin Pharmacol. Appl. Skin Physiol. 16:108–116.
  • Miyazaki, K. (2004). Topical application of Bifidobacterium-fermented soy milk extract containing genistein and daidzein improves rheological and physiological properties of skin. J. Cosmet. Sci. 55:473–479.
  • Mohammadi, R. and Mortazavian, A.M. (2010). Technological aspects of prebiotics in probiotic fermented milks. Food Rev. Int. 27:192–212.
  • Moro, G., Arslanoglu, S. and Stahl, B. (2006). A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 91:814–819.
  • Moyal, D. and Fourtanier, A. (2004). Acute and chronic effects of UV on skin. In: Photoaging. Rigel, D.S., Weiss, R.A., Lim, H.W. and Dover, J.S., Eds., Marcel Dekker, New York.
  • Mucid, D. and Salek-Ardekani, S.H. (2009). Regulation of TH17 cells in the mucosal surfaces. J. Allergy Clin. Immunol. 123:997–1003.
  • Negoro, T., Orihara, K. and Irahara, T. (2006). Influence of SNPs in cytokine-related genes on the severity of food allergy and atopic eczema in children. Pediatr. Allergy Immunol. 17:583–590.
  • Netea, M.G., Van der Meer, J.W. and Kullberg, B.J. (2004). Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol. 12:484–488.
  • Niers, L., Martín, R., Rijkers, G., Sengers, F., Timmerman, H., van Uden, N., Smidt, H., Kimpen, J. and Hoekstra, M. (2009). The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 64:1349–1358.
  • Niers, L., Timmerman, H., Rijkers, G., Van Bleek, G., van Uden, N. and Knol, E. (2005). Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines. Clin. Exp. Allergy 35:1481–1489.
  • Noverr, M.C., Falkowski, N. and Mcdonald, R.A. (2005). Development of allergic airway disease in mice following antibiotic therapy and fungal microbiota increase: Role of host genetics, antigen, and interleukin-13. Infect. Immunol. 73:30–38.
  • Noverr, M.C. and Huffnagle, G.B. (2004). Does the microbiota regulate immune responses outside the gut? Trends Microbiol. 12:562–568.
  • Noverr, M.C. and Huffnagle, G.B. (2005). The ‘‘microflora hypothesis’’ of allergic diseases. Clin. Exp. Allergy 35:1511–1520.
  • Ogden, N.S. and Bielory, L. (2005). Probiotics: A complementary approach in the treatment and prevention of pediatric atopic disease. Curr. Opin. Allergy Clin. Immunol. 5:179–184.
  • Oh, S., Kim, S.H., Ko, Y., Sim, J.H., Kim, K.S., Lee, S.H., Park, S. and Kim, Y.J. (2006). Effect of bacteriocin produced by Lactococcus sp. HY 449 on skin-inflammatory bacteria. Food Chem. Toxicol. 44:552–559.
  • Osborn, D. and Sinn, J. (2007). Probiotics in infants for prevention of allergic disease and food hypersensitivity [review]. Cochr. Database Syst. Rev. CD006474.
  • Ouwehand, A.C. (2007). Antiallergic effects of probiotics. J. Nutr. 137: 794S–797S.
  • Ouwehand, A.C., Båtsman, A. and Salminen, S. (2003). Probiotics for the skin: A new area of potential application? Letters Appl. Microbiol. 36:327–331.
  • Ouwehand, A.C., Salminen, S. and Isolauri, E. (2002). Probiotics: An overview of beneficial effects. Antonie van Leuwenhoek 82:279–289.
  • Paganelli, R., Ciuffreda, S., Verna, N., Cavallucci, E., Paolini, F., Ramondo, S. and Di Gioacchino, M. (2002). Probiotics and food-allergic diseases. Allergy 57:97–99.
  • Passeron, T. and Lacour, J. (2005). Effects of probiotics on atopic dermatitis. Arch. Dis. Child. 20:171–176.
  • Passeron, T., Lacour, J.P. and Fontas, E. (2006). Prebiotics and synbiotics: Two promising approaches for the treatment of atopic dermatitis in children above 2 years. Allergy 61:431–437.
  • Pavicic, T., Wollenweber, U., Farwick, M. and Korting, H.C. (2007). Anti-microbial and -inflammatory activity and efficacy of phytosphingosine: An in vitro and in vivo study addressing acne vulgaris. Int. J. Cosmet Sci. 29:181–190.
  • Peguet-Navarro, J., Dezutter-Dambuyant, C., Buetler, T.M., Leclaire, J., Smola, H., Blum, S., Bastien, P., Breton, L. and Gueniche, A. (2008). Supplementation with oral probiotic bacteria protects human cutaneous immune homeostasis after UV exposure-double blind, randomized, placebo controlled clinical trial. Eur. J. Dermatol. 18:504–511.
  • Pelto, L., Isolauri, E., Lilius, E.-M., Nuutila, J. and Salminen, S. (1998). Probiotic bacteria downregulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy 28:1474–1479.
  • Peňa, J., Rogers, A., Ge, Z., Ng, V., Li, S., Fox, J. and Versalovic, J. (2005). Probiotic Lactobacillus spp diminish Helicobacter hepaticus-induced inflammatory bowel disease in Interleukin-10-deficient mice. Infect. Immunol. 73:912–920.
  • Penders, J., Stobberingh, E.E., Thijs, C., Adams, H., Vink, C., van Ree, R. and van den Brandt, P.A. (2006). Molecular finger printing of the intestinal microbiota of infants in whom atopic eczema was or was not developing. Clin. Exp. Allergy 36:1602–1608.
  • Peral, M.C., Martinez, M.A. and Valdez, J.C. (2009a). Bacteriotherapy with Lactobacillus plantarum in burns. Int. Wound J. 6:73–81.
  • Peral, M.C., Rachid, M.M., Gobbato, N.M., Martinez, M.A. H. and Valdez, J.C. (2009b). Interleukin-8 production by polymorphonuclear leukocytes from patients with chronic infected leg ulcers treated with Lactobacillus plantarum. Clin. Microbiol. Infect. 16:281–286.
  • Peran, L., Camuesco, D., Comalada, M., Nieto, A., Concha, A., Adrio, J.L., Olivares, M., Xaus, J.Z. A. and Galvez, J. (2006). Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis. Int. J. Colorectal Dis. 21:737–746.
  • Pike, M.G., Heddle, R.J., Boulton, P., Turner, M.W. and Atherton, D.J. (1986). Increased intestinal permeability in atopic dermatitis. J. Invest. Dermatol. 110:101–104.
  • Pillai, S., Oresajo, C. and Hayward, J. (2005). Ultraviolet radiation and skin aging: Role of reactive oxygen species, inflammation and protease activation, and strategies for prevention of inflammation induced: A review. Int. J. Cosmet. Sci. 27:17–34.
  • Pohjavuori, E., Viljanen, M. and Korpela, R. (2004). Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J. Allergy Clin. Immunol. 114:131–136.
  • Prescott, S. and Bjorksten, B. (2007). Probiotics for the prevention or treatment of allergic diseases. J. Allergy Clin. Immunol. 120:255–262.
  • Prescott, S.L., Dunstan, J.A. and Hale, J. (2005). Clinical effects of probiotics are associated with increased interferon-gamma responses in very young children with atopic dermatitis. Clin. Exp. Allergy 35:1557–1564.
  • Pucci, N., Novembre, E., Cammarata, M.G., Bernardini, R., Monaco, M.G., Calogero, C. and Vierucci, A. (2005). Scoring atopic dermatitis in infants and young children: Distinctive features of the SCORAD index. Allergy 60:113–116.
  • Puch, F., Samson-Villeger, S., Guyonnet, D., Blachon, J.L., Rawlings, A.V. and Lassel, T. (2008). The consumption of functional fermented milk containing borage oil, green tea and vitamin E enhances skin barrier function. Exp. Dermatol. 7:668–674.
  • Quadros, E., Landzert, N.M., Leroy, S., Gasparini, F. and Worosila, G. (1994). Colonic absorption of insulin-like growth factor I in vitro. Pharm. Res. 11:226–230.
  • Rautava, S., Kalliomäki, M. and Isolauri, E. (2002). Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. JACI, 109–121.
  • Rautava, S., Kalliomaki, M. and Isolauri, E. (2005). New therapeutic strategy for combating the increasing burden of allergic disease: Probiotics-A nutrition, allergy, mucosal immunology and intestinal microbiota (NAMI) research group report. J. Allergy Clin. Immunol. 116:31–37.
  • Rijken, F., Kiekens, R.C. M. and Bruijnzeel, P.L. B. (2005). Skin-infiltrating neutrophils following exposure to solar-simulated radiation could play an important role in photoageing of human skin. Br. J. Dermatol. 152:321–328.
  • Rittié, L. and Fisher, G.J. (2002). UV-light-induced signal cascades and skin aging. Ageing Res. Rev. 1:705–720.
  • Roberfroid, M., Gibson, G.R., Hoyles, L., Mccartney, A.L., Rastall, R. and Rowland, I. (2010). Prebiotic effects: Metabolic and health benefits. Br. J. Nutr. 104:S1–S63.
  • Rodriguez, K.L., Caputo, L.R. G., Carvalho, J.C. T., Evangelista, J. and Schneedorf, J.M. (2005). Antimicrobial and healing activity of kefir and kefiran extract. Int. J. Antimicrobial. Agents. 25:404–408.
  • Romagnani, S. (1996). Thiand Th2 in human diseases. Clin. Immunol. Immunopathol. 80:225–235.
  • Rosen, L.D. and Breuner, C.C. (2007). Primary care from infancy to adolescence. Pediatr. Clin. N. Am. 54:837–858.
  • Rosenfeldt, V., Benfeldt, E. and Nielsen, S.D. (2003). Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 111:389–395.
  • Rosenfeldt, V., Benfeldt, E., Valerius, N.H., Pærregaard, A. and Michaelsen, K.F. (2004). Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J. Pediatr. 145:612–616.
  • Salminen, S.J., Gueimonde, M. and Isolauri, E. (2005). Probiotics that modify disease risk. J. Nutr. 135:1294–1298.
  • Sato, A., Hashiguchi, M., Toda, E., Iwasaki, A., Hachimura, S. and Kaminogawa, S. (2003). CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells. J. Immunol. 171:3684–3690.
  • Schiffrin, E.J., Thomas, D.R., Kumar, V.B., Brown, C., Hager, C. and Van't Hof, M.A. (2007). Systemic inflammatory markers in older persons: The effect of oral nutritional supplementation with prebiotics. J. Nutr. Health. Aging 11:475–479.
  • Schmidt, W.P. (2004). Model of the epidemic of childhood atopy. Med. Sci. Monit. 10:5–9.
  • Schultz-Larsen, F.H. J. (2002). Epidemiology of atopic dermatitis. Immunol. Allergy Clin. North Am. 22:1–24.
  • Seifert, S. and Watzl, B. (2007). Inulin and oligofructose: Review of experimental data on immune modulation. J. Nutr. 137:2563–2567.
  • Shen, Q., Zhang, B., Xu, R., Wang, Y., Ding, X. and Li, P. (2010). Antioxidant activity in vitro of the selenium-contained protein from the Se-enriched Bifidobacterium animalis 01. Anaerobe 16:380–386.
  • Shida, K., Makino, K. and Morishita, A. (1998). Lactobacillus casei inhibits antigeninduced IgE secretion through regulation of cytokine production in murine splenocyte cultures. Int. Arch. Allergy Immunol. 115:278–287.
  • Sicherer, S.H. and Sampson, H.A. (1999). Food hypersensitivity and atopic dermatitis: Pathophysiology, epidemiology, diagnosis, and management. J. Allergy Clin. Immunol. 104:S114–S122.
  • Simmering, R. and Breves, R. (2009). Pre- and probiotic cosmetics. Hautarzt 60:809–814.
  • Sistek, D., Kelly, R., Wickens, K., Stanley, T., Fitzharris, P. and Crane, J. (2006). Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp. Allergy 36:629–633.
  • Smits, H.H., Engering, A. and van der Kleij, D. (2005). Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin. J. Allergy Clin. Immunol. 115:1260–1267.
  • Soter, N.A. (1990). Acute effects of ultraviolet radiation on the skin. Semin. Dermatol. 9:11–15.
  • Sullivan, M., Schnittger, S.F., Mammone, T. and Goyarts, E.C. (2009). Skin Treatment Method with Lactobacillus Extract. US Patent, US7510734B2.
  • Tannis, A. (2008). The Future of Probiotics: Superbugs, Asthma, Oral Health and More. Wiley, Mississauga, Canada.
  • Tannock, G.W. (1995). Normal Microflora. An Introduction to Microbes Inhabiting the Human Body. Chapman & Hall, London, UK.
  • Taylor, A.L., Hale, J., Wiltschut, J., Lehmann, H., Dunstan, J.A. and Prescott, S.L. (2006). Effects of probiotic supplementation for the first 6 months of life on allergen-and vaccine-specific immune responses. Clin. Exp. Allergy 36:1227–1235.
  • Taylor, A., Dunstan, J. and Prescott, S. (2007). Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. J. Allergy Clin. Immunol. 119:184–191.
  • Teodorescu, R. (1999). A Natural Eubiotic Product for Maintenance and Treatment of Teguments. WIPO Patent, WO1999007332.
  • Trautmann, A., Akdis, M., Schmid-Grendelmeier, P., Disch, R., Bröocker, E.B., Blaser, K. and Akdis, C.A. (2001). Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis. J. Allergy Clin. Immunol. 108:839–846.
  • Vaarala, O. (2003). Immunological effects of probiotics with special reference to lactobacilli. Clin. Exp. Allergy 33:1634–1640.
  • Valdéz, J.C., Peral, M.C., Rachid, M., Santana, M. and Perdigón, G. (2005). Interference of Lactobacillus plantarum with Pseudomonas aeruginosa in vitro and in infected burns: The potential use of probiotics in wound treatment. Clin. Microbiol. Infect. 11:472–479.
  • van der Aa, L.B., Heymans, H.S., van Aalderen, W.M. and Al., E. (2010). The Synbad Study Group. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Clin. Exp. Allergy 40:795–804.
  • Veckman, V., Miettinen, M., Pirhonen, J., Siren, J., Matikainen, S. and Julkunen, I. (2004). Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol. 75:764–771.
  • Viljanen, M., Savilahti, E. and Haahtela, T. (2005). Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: A double-blind placebocontrolled trial. Allergy 60:494–500.
  • Volkova, L.A., Khalif, I.L. and Kabanova, I.N. (2001). Impact of the impaired intestinal microflora on the course of acne vulgaris. Klin. Med. 79:39–41.
  • von Hertzen, L.C., Savolainen, J., Hannuksela, M., Klaukka, T., Lauerma, A., Mäkelä, M.J., Pekkanen, J., Pietinalho, A., Vaarala, O., Valovirta, E., Vartiainen, E. and Haahtela, T. (2009). Scientific rationale for the finnish allergy programme 2008–2018: Emphasis on prevention and endorsing tolerance. Allergy 64:678–701.
  • Weston, S., Halbert, A. and Richmond, P. (2005). Effects of probiotics on atopic dermatitis: A randomised controlled trial. Arch. Dis. Child. 90:892–897.
  • Wickens, K., Black, P.N., Stanley, T.V., Mitchell, E., Fitzharris, P., Tannock, G.W., Purdie, G. and Crane, J. (2008). A differential effect of 2 probiotics in the prevention of eczema and atopy: A double-blind, randomized, placebocontrolled trial. J. Allergy. Clin. Immunol. 122:788–794.
  • Winkler, P., Ghadimi, D., Schrezenmeir, J. and Kraehenbuhl, J.P. (2007). Molecular and cellular basis of microflorahost interactions. J. Nutr. 137:756S–772S.
  • Woods, G.M., Malley, R.C. and Muller, H.K. (2005). The skin immune system and the challenge of tumour immunosurveillance. Eur. J. Dermatol. 15:63–69.
  • Xu, Y. and Fisher, G.J. (2005). Ultraviolet (UV) light irradiation induced signal transduction in skin photoaging. J. Dermatol. Sci. 1:S1–S8.
  • Yamamoto, A., Takenouchi, K. and Ito, M. (1995). Impaired water barrier function in acne vulgaris. Arch. Dermatol. Res. 287:214–218.
  • Yoshimura, A., Lien, E., Ingalls, R.R., Tuomanen, E., Dziarski, R. and Golenbock, D. (1999). Cutting edge: Recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163:1–5.
  • Zeuthen, L., Christensen, H.R. and Frøkiær, H. (2005). Lactic acid bacteria inducing a weak Interleukin-12 and Tumour Necrosis Factor Alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gram negative bacteria. Clin. Vaccine Immunol. 13:365–375.
  • Zutavern, A., Brockow, I. and Schaaf, B. (2006). Timing of solid food introduction in relation to atopic dermatitis and atopic sensitization: Results from a prospective birth cohort study. LISA Study Group. Pediatrics 117:401–411.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.